Methicillin-resistant versus methicillin-sensitive Staphylococcus aureus infective endocarditis

被引:39
作者
Hill, E. E. [3 ]
Peetermans, W. E. [3 ]
Vanderschueren, S. [3 ]
Claus, P. [2 ]
Herregods, M. -C. [2 ]
Herijgers, P. [1 ]
机构
[1] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Cardiac Surg, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Cardiol, B-3000 Louvain, Belgium
[3] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Internal Med Infect Dis, B-3000 Louvain, Belgium
关键词
D O I
10.1007/s10096-007-0458-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The incidence of methicillin-resistant Staphylococcus aureus (MRSA) infective endocarditis (IE) is increasing. This study compared clinical characteristics and mortality in patients with methicillin-sensitive S. aureus (MSSA) IE versus MRSA IE, based on a prospectively collected series of 72 consecutive patients with definite S. aureus IE according to the modified Duke criteria between June 2000 and December 2006. Sixteen of 72 IE patients (22%) were caused by MRSA. Nosocomial origin, surgical site infection, surgery in the previous 6 months, the presence of a catheter and persistent bacteremia were significantly associated with MRSA. MSSA patients had significantly more unknown origin of bacteremia and experienced a significantly higher rate of major embolism than MRSA patients. MSSA patients underwent more frequently combined surgical and antimicrobial therapy, and MRSA patients were treated more frequently with antimicrobial therapy due to a contraindication to surgery. The 6-month mortality was higher in patients with MRSA than MSSA. In the MSSA group treated with antimicrobial therapy without an indication to surgery, all patients survived, and in the combined surgical and antimicrobial group 29% died. The mortality in MRSA patients was lowest if combined surgical and antimicrobial therapy was performed. Both in MSSA and MRSA patients with antimicrobial therapy due to a contraindication to surgery, the mortality was extremely high. These data suggest that in S. aureus IE patients with a nosocomial origin, the presence of a catheter or recent surgery, initial therapy should include antimicrobial agents active against MRSA. Antimicrobial therapy alone with close monitoring of the therapeutic effect and signs of complicated course is an acceptable approach in selected patients with MSSA IE. Denial of surgery because of local or general factors in patients that meet criteria for surgical intervention in acute IE is prognostically ominous.
引用
收藏
页码:445 / 450
页数:6
相关论文
共 21 条
[1]   Infective endocarditis - Diagnosis, antimicrobial therapy, and management of complications - A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association - Executive summary [J].
Baddour, LM ;
Wilson, WR ;
Bayer, AS ;
Fowler, VG ;
Bolger, AF ;
Levison, ME ;
Ferrieri, P ;
Gerber, MA ;
Tani, LY ;
Gewitz, MH ;
Tong, DC ;
Steckelberg, JM ;
Baltimore, RS ;
Shulman, ST ;
Burns, JC ;
Falace, DA ;
Newburger, JW ;
Pallasch, TJ ;
Takahashi, M ;
Taubert, KA .
CIRCULATION, 2005, 111 (23) :3167-3184
[2]   Use of surgery in patients with native valve infective endocarditis: Results from the International Collaboration on Endocarditis Merged Database [J].
Cabell, CH ;
Abrutyn, E ;
Fowler, VG ;
Hoen, B ;
Miro, JM ;
Corey, R ;
Olaison, L ;
Pappas, P ;
Anstrom, KJ ;
Stafford, JA ;
Eykyn, S ;
Habib, G ;
Mestres, CA ;
Wang, A .
AMERICAN HEART JOURNAL, 2005, 150 (05) :1092-1098
[3]   A prospective multicenter study of Staphylococcus aureus bacteremia -: Incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance [J].
Chang, FY ;
MacDonald, BB ;
Peacock, JE ;
Musher, DM ;
Triplett, P ;
Mylotte, JM ;
O'Donnell, A ;
Wagener, MM ;
Yu, VL .
MEDICINE, 2003, 82 (05) :322-332
[4]   A COMPARISON OF HOSPITAL AND COMMUNITY-ACQUIRED INFECTIVE ENDOCARDITIS [J].
CHEN, SCA ;
DWYER, DE ;
SORRELL, TC .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (18) :1449-1452
[5]   Staphylococcus aureus endocarditis -: A consequence of medical progress [J].
Fowler, VG ;
Miro, JM ;
Hoen, B ;
Cabell, CH ;
Abrutyn, E ;
Rubinstein, E ;
Corey, GR ;
Spelman, D ;
Bradley, SF ;
Barsic, B ;
Pappas, PA ;
Anstrom, KJ ;
Wray, D ;
Fortes, CQ ;
Anguera, I ;
Athan, E ;
Jones, P ;
van der Meer, JTM ;
Elliott, TSJ ;
Levine, DP ;
Bayer, AS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (24) :3012-3021
[6]   Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study [J].
Hill, Evelyn E. ;
Herijgers, Paul ;
Claus, Piet ;
Vanderschueren, Steven ;
Herregods, Marie-Christine ;
Peetermans, Willy E. .
EUROPEAN HEART JOURNAL, 2007, 28 (02) :196-203
[7]   Guidelines on prevention, diagnosis and treatment of infective endocarditis - Executive summary [J].
Horstkotte, D ;
Follath, F ;
Gutschik, E ;
Lengyel, M ;
Oto, A ;
Pavie, A ;
Soler-soler, J ;
Thiene, G ;
von Graevenitz, A .
EUROPEAN HEART JOURNAL, 2004, 25 (03) :267-276
[8]   Risk factors for nosocomial infective endocarditis in patients with methicillin-resistant Staphylococcus aureus bacteremia [J].
Hsu, RB .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2005, 26 (07) :654-657
[9]   SLOW RESPONSE TO VANCOMYCIN OR VANCOMYCIN PLUS RIFAMPIN IN METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS ENDOCARDITIS [J].
LEVINE, DP ;
FROMM, BS ;
REDDY, BR .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (09) :674-680
[10]   Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis [J].
Li, JS ;
Sexton, DJ ;
Mick, N ;
Nettles, R ;
Fowler, VG ;
Ryan, T ;
Bashore, T ;
Corey, GR .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (04) :633-638